← CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL
Market Price
$279.72
Market Cap
$13.55B
P/E Ratio
N/A
Revenue (FY 2025)
↓-0.9% YoY
$4.02B
3-Yr CAGR: 0.3%
Net Income
↓-750.1% YoY
-$144.34M
Net Margin: -3.6%
Free Cash Flow
↑3.4% YoY
$518.49M
FCF Yield: 3.83%
EPS (Diluted)
↓-1,555.0% YoY
$-2.91
Basic: $-2.91
Return on Equity
Efficiency
-4.6%
ROA: -111.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CRL)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,681.4M | — | $1,404.4M | $154.8M | — | $3.23 | — | $300.4M | $245.1M | — |
| FY 2017 | $1,857.6M | +10.5% | $1,567.9M | $123.4M | -20.3% | $2.54 | -21.4% | $318.1M | $235.6M | -3.9% |
| FY 2018 | $2,266.1M | +22.0% | $775.2M | $226.4M | +83.5% | $4.62 | +81.9% | $441.1M | $301.1M | +27.8% |
| FY 2019 | $2,621.2M | +15.7% | $868.8M | $252.0M | +11.3% | $5.07 | +9.7% | $480.9M | $340.4M | +13.1% |
| FY 2020 | $2,923.9M | +11.5% | $961.7M | $364.3M | +44.6% | $7.20 | +42.0% | $546.6M | $380.0M | +11.6% |
| FY 2021 | $3,540.2M | +21.1% | $1,209.8M | $391.0M | +7.3% | $7.60 | +5.6% | $760.8M | $532.0M | +40.0% |
| FY 2022 | $3,976.1M | +12.3% | $1,316.1M | $486.2M | +24.4% | $9.48 | +24.7% | $619.6M | $294.9M | -44.6% |
| FY 2023 | $4,129.4M | +3.9% | $1,365.1M | $474.6M | -2.4% | $9.22 | -2.7% | $683.9M | $365.4M | +23.9% |
| FY 2024 | $4,050.0M | -1.9% | $978.4M | $22.2M | -95.3% | $0.20 | -97.8% | $734.6M | $501.6M | +37.3% |
| FY 2025 | $4,015.4M | -0.9% | $768.2M | $-144.3M | -750.1% | $-2.91 | -1,555.0% | $737.6M | $518.5M | +3.4% |
Valuation
Market Price
$279.72
Market Cap
$13.55B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
4.26
FCF Yield
3.83%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
19.13%
Operating Margin
0.63%
Net Margin
-3.59%
Return on Equity (ROE)
-4.56%
Return on Assets (ROA)
-111.71%
Asset Turnover
31.08x
Revenue 3-Yr CAGR
0.33%
Financial Health & Liquidity
Current Ratio
0.48
Cash Ratio
0.79
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$213.77M
Total Debt
N/A
Book Value / Share
$65.70
Cash Flow Efficiency
Operating Cash Flow
$737.65M
Capital Expenditures (CapEx)
$219.15M
Free Cash Flow
$518.49M
OCF / Revenue
18.37%
FCF / Revenue
12.91%
FCF 3-Yr CAGR
20.69%
Per Share Metrics
EPS (Diluted)
$-2.91
EPS (Basic)
$-2.91
Dividends / Share
N/A
Book Value / Share
$65.70
EPS YoY Growth
-1,555.00%
Balance Sheet (FY 2025)
Total Assets
$129.21M
Total Liabilities
$270.08M
Stockholders' Equity
$3.16B
Current Assets
$129.21M
Current Liabilities
$270.08M